RhumbLine Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92M | Buy |
367,086
+14,370
| +4% | +$310K | 0.01% | 1169 |
|
|
2025
Q1 | $5.86M | Buy |
352,716
+177,188
| +101% | +$2.94M | 0.01% | 1273 |
|
|
2024
Q4 | $3.22M | Sell |
175,528
-2,613
| -1% | -$47.9K | ﹤0.01% | 1637 |
|
|
2024
Q3 | $2.74M | Sell |
178,141
-8,359
| -4% | -$129K | ﹤0.01% | 1724 |
|
|
2024
Q2 | $3.03M | Buy |
186,500
+2,121
| +1% | +$34.5K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $3.41M | Buy |
184,379
+1,095
| +0.6% | +$20.2K | ﹤0.01% | 1618 |
|
|
2023
Q4 | $5.74M | Sell |
183,284
-1,116
| -0.6% | -$34.9K | 0.01% | 1332 |
|
|
2023
Q3 | $3.84M | Buy |
184,400
+3,624
| +2% | +$75.5K | ﹤0.01% | 1499 |
|
|
2023
Q2 | $4.33M | Buy |
180,776
+6,977
| +4% | +$167K | ﹤0.01% | 1464 |
|
|
2023
Q1 | $3.27M | Buy |
173,799
+917
| +0.5% | +$17.3K | ﹤0.01% | 1561 |
|
|
2022
Q4 | $2.75M | Buy |
172,882
+5,322
| +3% | +$84.7K | ﹤0.01% | 1618 |
|
|
2022
Q3 | $2.74M | Buy |
167,560
+16,545
| +11% | +$271K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $2.13M | Buy |
151,015
+17,571
| +13% | +$248K | ﹤0.01% | 1734 |
|
|
2022
Q1 | $3.23M | Buy |
133,444
+5,011
| +4% | +$121K | ﹤0.01% | 1571 |
|
|
2021
Q4 | $3M | Sell |
128,433
-1,740
| -1% | -$40.6K | ﹤0.01% | 1663 |
|
|
2021
Q3 | $2.16M | Buy |
130,173
+1,651
| +1% | +$27.4K | ﹤0.01% | 1872 |
|
|
2021
Q2 | $3.14M | Buy |
128,522
+12,840
| +11% | +$313K | ﹤0.01% | 1700 |
|
|
2021
Q1 | $2.99M | Sell |
115,682
-9,114
| -7% | -$235K | ﹤0.01% | 1710 |
|
|
2020
Q4 | $6.67M | Buy |
124,796
+100
| +0.1% | +$5.35K | 0.01% | 1186 |
|
|
2020
Q3 | $5.14M | Sell |
124,696
-7,515
| -6% | -$310K | 0.01% | 1152 |
|
|
2020
Q2 | $6.41M | Sell |
132,211
-30,324
| -19% | -$1.47M | 0.01% | 1051 |
|
|
2020
Q1 | $6.87M | Buy |
162,535
+1,758
| +1% | +$74.3K | 0.01% | 846 |
|
|
2019
Q4 | $6.88M | Buy |
160,777
+13,709
| +9% | +$586K | 0.01% | 1068 |
|
|
2019
Q3 | $5.29M | Sell |
147,068
-3,462
| -2% | -$125K | 0.01% | 1158 |
|
|
2019
Q2 | $4.02M | Buy |
150,530
+462
| +0.3% | +$12.4K | 0.01% | 1321 |
|
|
2019
Q1 | $4.03M | Buy |
150,068
+17,252
| +13% | +$463K | 0.01% | 1300 |
|
|
2018
Q4 | $2.15M | Buy |
132,816
+44,513
| +50% | +$720K | ﹤0.01% | 1600 |
|
|
2018
Q3 | $1.83M | Sell |
88,303
-6,015
| -6% | -$125K | ﹤0.01% | 1707 |
|
|
2018
Q2 | $1.44M | Sell |
94,318
-7,910
| -8% | -$121K | ﹤0.01% | 1851 |
|
|
2018
Q1 | $2.3M | Sell |
102,228
-6,132
| -6% | -$138K | ﹤0.01% | 1519 |
|
|
2017
Q4 | $3.26M | Sell |
108,360
-2,734
| -2% | -$82.3K | 0.01% | 1329 |
|
|
2017
Q3 | $4.19M | Sell |
111,094
-4,682
| -4% | -$176K | 0.01% | 1146 |
|
|
2017
Q2 | $3.23M | Sell |
115,776
-1,573
| -1% | -$43.9K | 0.01% | 1271 |
|
|
2017
Q1 | $4.03M | Sell |
117,349
-340
| -0.3% | -$11.7K | 0.01% | 1140 |
|
|
2016
Q4 | $3.39M | Buy |
117,689
+9,006
| +8% | +$260K | 0.01% | 1141 |
|
|
2016
Q3 | $3.46M | Buy |
108,683
+9,653
| +10% | +$307K | 0.01% | 1091 |
|
|
2016
Q2 | $3.22M | Buy |
99,030
+18,190
| +23% | +$591K | 0.01% | 1060 |
|
|
2016
Q1 | $2.26M | Buy |
80,840
+6,150
| +8% | +$172K | 0.01% | 1290 |
|
|
2015
Q4 | $2.66M | Buy |
74,690
+1,715
| +2% | +$61.1K | 0.01% | 1170 |
|
|
2015
Q3 | $2.41M | Buy |
72,975
+1,522
| +2% | +$50.3K | 0.01% | 1214 |
|
|
2015
Q2 | $2.99M | Sell |
71,453
-2,800
| -4% | -$117K | 0.01% | 1145 |
|
|
2015
Q1 | $2.42M | Buy |
74,253
+11,685
| +19% | +$381K | 0.01% | 1272 |
|
|
2014
Q4 | $1.99M | Sell |
62,568
-595
| -0.9% | -$18.9K | 0.01% | 1350 |
|
|
2014
Q3 | $1.56M | Sell |
63,163
-4,090
| -6% | -$101K | ﹤0.01% | 1490 |
|
|
2014
Q2 | $1.52M | Buy |
67,253
+4,996
| +8% | +$113K | ﹤0.01% | 1555 |
|
|
2014
Q1 | $1.52M | Sell |
62,257
-3,240
| -5% | -$78.8K | ﹤0.01% | 1533 |
|
|
2013
Q4 | $1.64M | Buy |
65,497
+3,270
| +5% | +$81.7K | ﹤0.01% | 1492 |
|
|
2013
Q3 | $1.71M | Buy |
62,227
+8,827
| +17% | +$242K | 0.01% | 1446 |
|
|
2013
Q2 | $969K | Buy |
+53,400
| New | +$969K | ﹤0.01% | 1786 |
|